WEC
ONCY

Winslow Evans & Crocker’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Winslow Evans & Crocker’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-750
Closed -$1K – 1467
2013
Q4 		$1K Buy
+750
New +$1.69K ﹤0.01% 1378

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return

Winslow Evans & Crocker's ONCY Position: Q1 2014 in Review

Winslow Evans & Crocker sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2014, closing a stake of 750 shares — an estimated $1K sold.

Winslow Evans & Crocker first reported a position in ONCY in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 34 funds tracked by Wall St. Rank hold ONCY as of Q1 2014.

  • Winslow Evans & Crocker reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2014 after selling out during the quarter.
  • Winslow Evans & Crocker sold 750 ONCOLYTICS BIOTECH INC shares in Q1 2014, an estimated $1K.
  • Winslow Evans & Crocker first reported a position in ONCOLYTICS BIOTECH INC in Q4 2013 and held it in 1 quarter.
  • Winslow Evans & Crocker's ONCOLYTICS BIOTECH INC position peaked at $1K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2014.

Based on Winslow Evans & Crocker's 13F filing for Q1 2014, filed 11 Apr 2014.